CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The Mitigating Antimalarial Resistance Consortium for South-East Africa focuses on addressing the emergence of artemisinin-resistant malaria parasites. The project aims to improve treatment guidelines and develop action plans to combat drug resistance through collaboration with healthcare providers and policymakers.
BACKGROUND:
Gains achieved in reducing the burden of malaria and advancing its elimination are now threatened by the independent emergence and local spread of artemisinin-resistant parasites in East Africa.
Protecting the efficacy of the current first-line malaria treatments, all of which are artemisinin-based, is now a top public health priority.
OBJECTIVE:
The Mitigating Antimalarial Resistance Consortium for South-East Africa (MARC SE-Africa) is designed to promote the translation of evidence…
UNIVERSITY OF CAPE TOWN
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Netherlands, Amsterdam
Type: Research institute
Activity type: Research Organisations
SME: No
Sweden, Stockholm
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
United Kingdom, Oxford
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
